Vertex Pharmaceuticals Says FDA Approved Casgevy for TDT Patients

By Will Feuer Vertex Pharmaceuticals said the U.S. Food and Drug Administration has approved its Casgevy drug for the treatment of transfusion-dependent beta...

Related Keywords

,Drug Administration ,Vertex Pharmaceuticals ,Nobel Prize Winning ,Will Feuer ,Article Normal ,Pharmaceuticals ,Scientific Research Services ,Healthcare Life Sciences ,Business Consumer Services ,Medical Research Services ,Drug Discovery Development ,Healthcare Support Services ,Diagnostic Medical Research Services ,Regulation Government Policy ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Blood Donations Transfusions ,Political General News ,Health ,Medical Treatments Procedures ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Vrtx ,Regulation ,Government Policy ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,Blood Donations ,Transfusions ,Political ,General News ,Medical Treatments ,Procedures ,Healthcare ,Life Sciences ,Business ,Consumer Services ,Drug Discovery ,Development ,Diagnostic ,